Pevesa Biotech Overview
- Year Founded
-
1996
- Status
-
Acquired/Merged
- Employees
-
17
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
Pevesa Biotech General Information
Description
Operator of a biotechnology research platform designed to develop and manufacture nutritional food ingredients and protein derivatives. The company's biotechnology research platform focuses on working with proteins to obtain isolate, hydrolysates, peptides and amino acids, enabling consumers to have healthy food and supplements.
Contact Information
Website
www.pevesa.comCorporate Office
- Avda de la Industria s/n, P.I Poliviso
- El Viso del Alcor
- 41520 Sevilla
- Spain
Corporate Office
- Avda de la Industria s/n, P.I Poliviso
- El Viso del Alcor
- 41520 Sevilla
- Spain
Pevesa Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Pevesa Biotech Comparisons
Industry
Financing
Details
Pevesa Biotech Competitors (1)
One of Pevesa Biotech’s competitors is AMCO Proteins, a Private Debt Financed company based in Burlington, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AMCO Proteins | Private Debt Financed | Burlington, NJ |
Pevesa Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Pevesa Biotech Patents
Pevesa Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2559902-B1 | Procedure for reducing contaminants in protein plant matter | Active | 11-Nov-2015 | ||
| EP-3375290-A2 | Procedure for reducing contaminants in vegetable protein matter | Pending | 11-Nov-2015 | ||
| ES-2559902-A1 | Procedure to reduce contaminants in plant protein (machine-translation by google translate, not legally binding) | Active | 11-Nov-2015 | ||
| EP-3400806-A1 | Procedure for reducing contaminants in vegetable protein matter | Pending | 11-Nov-2015 | ||
| US-20190029295-A1 | Procedure for reducing contaminants in vegetable protein matter | Inactive | 11-Nov-2015 | A23L5/25 |
Pevesa Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Pevesa Biotech Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Pevesa Biotech FAQs
-
When was Pevesa Biotech founded?
Pevesa Biotech was founded in 1996.
-
Where is Pevesa Biotech headquartered?
Pevesa Biotech is headquartered in Sevilla, Spain.
-
What is the size of Pevesa Biotech?
Pevesa Biotech has 17 total employees.
-
What industry is Pevesa Biotech in?
Pevesa Biotech’s primary industry is Biotechnology.
-
Is Pevesa Biotech a private or public company?
Pevesa Biotech is a Private company.
-
What is Pevesa Biotech’s current revenue?
The current revenue for Pevesa Biotech is .
-
How much funding has Pevesa Biotech raised over time?
Pevesa Biotech has raised $2.07M.
-
Who are Pevesa Biotech’s investors?
Caixa Capital Risc, Milar Ventures, and Suanfarma Biotech have invested in Pevesa Biotech.
-
Who are Pevesa Biotech’s competitors?
AMCO Proteins is a competitor of Pevesa Biotech.
-
When was Pevesa Biotech acquired?
Pevesa Biotech was acquired on 01-Sep-2019.
-
Who acquired Pevesa Biotech?
Pevesa Biotech was acquired by Kerry Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
